← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MISSION PHARMACAL · Approved 2011-02-18

Drug application

FDA Application #

ANDA078974

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

GABAPENTIN

Active ingredients

GABAPENTIN

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

MISSION PHARMACAL

Manufacturer

BioComp Pharma, Inc.

First approval

2011-02-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown